Stay updated on Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page now shows recruitment is closed and adds new help sections, plus the Intervention/Treatment heading is updated and a prior version reference (v3.5.5) is replaced with v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the revision history without altering study content or details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This update appears to be a technical version change with no changes to the study details or displayed content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s footer revision identifier was updated from `v3.5.2` to `v3.5.3`, reflecting a site/software release rather than any change to the clinical trial information.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedSite revision updated from version 3.4.3 to 3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.